» Articles » PMID: 35496760

Multimodal Imaging Reveals Retinoschisis Masquerading As Retinal Detachment in Patients with Choroideremia

Overview
Specialty Ophthalmology
Date 2022 May 2
PMID 35496760
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To report three cases of retinoschisis in patients with intermediate to advanced choroideremia.

Observations: Three patients were referred for evaluation of retinal detachment in the context of an inherited retinal degenerative disease. In all three cases, patients carried variants in the gene suspected to be pathogenic and exhibited the characteristic findings of choroideremia, including pigment clumping and chorioretinal atrophy with scleral exposure and prominent choroidal vessels. Interestingly, these patients were also found to have areas of typical retinoschisis and cystoid degeneration located in the outer plexiform layer of the mid periphery or macula. Retinoschisis was confirmed by spectral domain optical coherence tomography (SD-OCT).

Conclusions/importance: This paper draws attention to the occurrence of retinoschisis in patients with choroideremia. OCT can be used to confirm the presence of retinoschisis rather than retinal detachment, as the clinical exam findings that distinguish the two conditions are not helpful in the setting of advanced chorioretinal atrophy. Although it remains unclear whether patients with choroideremia as a group are at increased risk of retinoschisis, it is possible that abnormal vesicular traffic in the RPE and photoreceptors could contribute to abnormalities in cell adhesion and the extracellular matrix. As gene therapy by subretinal injection of adeno-associated virus becomes the standard of care to slow down or arrest retinal degeneration in choroideremia, it will be critical to carefully screen these patients for retinoschisis prior to surgical intervention and to incorporate any such findings into surgical planning.

Citing Articles

The Value of Electroretinography in Identifying Candidate Genes for Inherited Retinal Dystrophies: A Diagnostic Guide.

Yang T, Kang E, Lin P, Wu P, Sachs J, Wang N Diagnostics (Basel). 2023; 13(19).

PMID: 37835784 PMC: 10572658. DOI: 10.3390/diagnostics13193041.


Cone Photoreceptor Morphology in Choroideremia Assessed Using Non-Confocal Split-Detection Adaptive Optics Scanning Light Ophthalmoscopy.

Xu P, Jiang Y, Morgan J Invest Ophthalmol Vis Sci. 2023; 64(10):36.

PMID: 37504961 PMC: 10383007. DOI: 10.1167/iovs.64.10.36.

References
1.
Buch H, Vinding T, Nielsen N . Prevalence and long-term natural course of retinoschisis among elderly individuals: the Copenhagen City Eye Study. Ophthalmology. 2007; 114(4):751-5. DOI: 10.1016/j.ophtha.2006.08.039. View

2.
Xue K, Jolly J, Barnard A, Rudenko A, Salvetti A, Patricio M . Beneficial effects on vision in patients undergoing retinal gene therapy for choroideremia. Nat Med. 2018; 24(10):1507-1512. PMC: 7032956. DOI: 10.1038/s41591-018-0185-5. View

3.
Mitsios A, Dubis A, Moosajee M . Choroideremia: from genetic and clinical phenotyping to gene therapy and future treatments. Ther Adv Ophthalmol. 2019; 10:2515841418817490. PMC: 6311551. DOI: 10.1177/2515841418817490. View

4.
Xue K, Groppe M, Salvetti A, MacLaren R . Technique of retinal gene therapy: delivery of viral vector into the subretinal space. Eye (Lond). 2017; 31(9):1308-1316. PMC: 5601444. DOI: 10.1038/eye.2017.158. View

5.
Simunovic M, Jolly J, Xue K, Edwards T, Groppe M, Downes S . The Spectrum of CHM Gene Mutations in Choroideremia and Their Relationship to Clinical Phenotype. Invest Ophthalmol Vis Sci. 2016; 57(14):6033-6039. PMC: 5102569. DOI: 10.1167/iovs.16-20230. View